摘要
目的探讨氨溴索联合阿奇霉素在治疗小儿支原体肺炎中的应用价值。方法将我院2011年3月至2013年3月收治的60例支原体肺炎患儿按不同治疗方式随机均分为对照组(常规治疗+阿奇霉素)和实验组(常规治疗+阿奇霉素+氨溴索),治疗1周后比较两组患儿治疗效果。结果实验组患儿治疗总有效率达到93.4%,明显高于对照组患儿的66.7%(P<0.05);实验组患儿咳嗽、发热等症状体征消退时间均明显短于对照组患儿(P<0.05)。结论氨溴索联合阿奇霉素治疗小儿支原体肺炎效果显著,症状改善明显,值得临床推广应用。
Objective To investigate the clinical value of ambroxol combined with azithromycin in the treatment of mycoplasma pneumonia. Methods 60 patients with mycoplasma pneumonia in our hospital from March 2011 to March 2013 were divided into the control group （azithromycin） and experimental group （azithromycin ＋ ambroxol）. The efficacies of two groups were compared after 7 days. Results The total effective-rate of experimental group was 93.4%, which was higher than that of control group （66.7%） （P 〈0.05）; the recovery time of clinical signs in experimental group including cough, fever clearance were shorter than those in control group （P〈0.05）. Conclusions The combination therapy ofambroxol combined with azithromycin for mycoplasma pneumonia has significant effect, which is worthy of clinical aoolication.
出处
《临床医学工程》
2013年第10期1249-1250,共2页
Clinical Medicine & Engineering
